დასაწყისი · კატალოგი · პროფილი · ცხრილი
დანამატები BODY HANDBOOK
დანამატები · §561
Vitamin D3 (cholecalciferol)
Roughly a third of adults in temperate countries walk into winter already short on it, and most of them never know. Vitamin D3 is the one supplement that's both genuinely studied at scale and genuinely cheap — a pill the price of nothing that sets a quiet floor under bone, immune function, and the slow background risk you carry into old age. The trials have been less flattering than the wellness world wants: it won't prevent cancer in healthy adults, it won't fix your mood if your levels are already fine, and the highest targets are sold harder than the data supports. What's left, after the hype settles, is still worth taking.
Do · Daily Evidence Moderate თავი დანამატები

A daily 1,000–2,000 IU softgel costs under fifteen dollars a year and takes the willpower of a toothbrush. The honest payoff is modest and slow — a small drop in respiratory infections, a small bend in long-term mortality, real relief if you turn out to be deficient — not the transformation a podcast might have promised. Take it daily, with food that has some fat, and skip the megadoses and the boutique combos.

Strictly speaking, vitamin D3 isn't a vitamin. It's a hormone precursor your skin makes from cholesterol when ultraviolet light hits it — the same way a leaf makes sugar from sunlight. Cod liver oil and salmon contribute a little; everything else is fortification, supplements, or your own skin. The liver converts what you absorb or make into a storage form called 25(OH)D — that's the number a vitamin D blood test reports — and the kidney converts that into the active hormone, which then walks into the nucleus of nearly every cell in your body and tells specific genes to switch on Holick 2007.

Which is why the same molecule turns up in conversations about bones, immunity, mood, cancer, and dying-of-old-age — and why none of those conversations is simple. The hormone is everywhere; the question is how much it actually does at each address. The body's setup, evolutionarily, was: stand outside half-naked, get plenty. The modern setup — desks, latitudes, sunscreen, winter — is one your physiology was never asked to handle, and a chunk of the adult population walks around with stored levels lower than any human in the species' history had until about two centuries ago.

What it actually does — and what it doesn't

The clearest case is the bottom of the range. Adults running below 20 ng/mL — about a third of US adults at any given moment, more in winter, more if you have darker skin or spend your days indoors Forrest & Stuhldreher 2011 — get measurable wins from replacement: less of the proximal-muscle fatigue that comes with running on empty, fewer respiratory infections, in older adults a real reduction in falls. Severe deficiency causes a disease called osteomalacia — soft bones, deep ache, weak hips and shoulders. Childhood version is rickets. These were epidemic in industrial Northern cities a century ago. Fortified milk and cod liver oil ended them.

What the last decade of large trials showed — and this is the part wellness culture has not fully absorbed — is that the picture above the deficient range gets a lot more modest, fast. The biggest single trial, VITAL, dosed 25,871 healthy adults at 2,000 IU/day for five years and watched for cancer, heart attacks, strokes, and depression. None of those endpoints moved.

What did survive the big-trial era: daily D3 nudges all-cause mortality down a little. The Cochrane review of 56 trials found D3 specifically — not the prescription form, D2 — cut mortality by about 6% Bjelakovic et al. 2014; the BMJ umbrella analysis put the number closer to 11% Chowdhury et al. 2014. Cancer-specific mortality moved in the same direction. The signal hinges on daily dosing — bolus doses (50,000+ IU monthly, or worse, annual mega-doses) don't show this benefit, and one famous annual-bolus trial actually increased falls and fractures Sanders et al. 2010. The body wants this hormone trickled in, not flooded.

The infection signal is real and worth understanding. A pooled analysis of every individual participant from 25 RCTs — not just trial-level numbers, individual data — found daily or weekly D3 reduced acute respiratory infections by about 12% across the whole population, and by a much larger margin in the people who started genuinely deficient Martineau et al. 2017. The dose-response is the giveaway: the worse off you were, the more replacement gave you back.

The cleanest read on everything else — mood, cognition, blood pressure, type 2 diabetes prevention, fractures in community-dwelling adults — is null or close to it. Smaller trials in deficient or seasonally-affected subgroups sometimes find something; the big trials in unselected populations rarely do. The lesson is consistent: D3 is mostly a deficiency-replacement story, not a more-is-better one.

The cost of not bothering

Skip this and the most likely outcome is: nothing visible, ever. That has to be said honestly. D3 isn't the entry where the missing version of you walks around with a face people stop recognising. The stakes are quieter than that, and they are real anyway.

The version of you who never sets the floor lives at a 25(OH)D somewhere in the teens through every winter, and the trade is paid in small, replicable ways. One more bad respiratory infection a year than the version who supplemented Martineau et al. 2017. A few more days of the deep proximal-muscle fatigue — the legs-feel-heavy-getting-up-from-a-chair kind — through February, dismissed as the season. Across decades, an actuarial drift in the wrong direction on all-cause mortality, small enough that nobody could point at a single year and call it the one you bought back, large enough to show up consistently in meta-analyses of tens of thousands of people Bjelakovic et al. 2014. In your seventies, when the falls start, the version who supplemented from middle age has slightly better odds of staying off the floor — that signal weakened in recent trials but never disappeared in the older, deficient populations the 700–1,000 IU trials were built on Bischoff-Ferrari et al. 2009.

None of this rises to fear-mongering. The honest forecast is the small one: a quietly elevated background risk through every winter you do not bother, paid in colds and fatigue and an old-age curve that bends slightly the wrong way.

How to take it

The whole protocol fits in a sentence: one D3 softgel with a meal that has some fat, every day, at a dose somewhere between 1,000 and 2,000 IU/day. Anything fancier is the supplement industry talking.

That is the whole thing. There is no protocol where you take 10,000 IU because of a paper you half-read, no need to retest every six months, no boutique combination product worth four times the price.

Who actually needs more

Vitamin D status splits the adult population sharper than almost any other nutrient. A few honest groupings, in descending order of "you should probably just take it":

  • Take it without testing first. Dark-skinned adults living above the latitude of Atlanta (roughly anywhere in Northern Europe, the upper US, Canada). Adults with a BMI over 30 — the molecule partitions into fat tissue, so you need two to three times the dose to reach the same blood level. Adults over 70, whose skin makes about half the vitamin D it did at 20. Anyone who is institutionalised, homebound, or veiled. Pregnant or breastfeeding women.
  • Test first, then decide. Indoor knowledge workers in temperate climates. Vegans without fortified-food intake. Adults aged 50–70 with no obvious sun exposure. The single test is cheap; the answer is usually "yes, take some," but knowing the starting number is worth $40.
  • Probably skip it. Outdoor workers in sunny climates. People who get an honest 15–30 minutes of midday sun on bare arms most days in summer and live somewhere the sun keeps working in winter. Adults who eat fatty fish more than twice a week. Your skin and your dinner plate are already doing the job.

The third group is smaller in the modern world than it sounds. If you commute, work indoors, and live anywhere north of Atlanta or south of Sydney, default to the first or second group.

When not to take it

For a supplement with a daily dose of 1,000–2,000 IU, the safety profile is among the cleanest in this catalogue. The conditions where caution is warranted are narrow and most readers will not have them — but they are real.

What the wellness world gets wrong

Vitamin D sits at the intersection of cheap supplement, dense literature, and a decade of confident podcasters; the misinformation has had a lot of room to grow. Four worth flagging:

"Most people are deficient." Depends entirely on where you draw the line. The Institute of Medicine calls 20 ng/mL sufficient; the Endocrine Society calls 30 ng/mL sufficient. Move the line ten units and you reclassify roughly half the country Forrest & Stuhldreher 2011, IOM 2011, Holick et al. 2011. The genuine clinical deficiency rate (below 20 ng/mL) is real but more like a third of adults, concentrated in identifiable groups. Calling 70% of the population "insufficient" is mostly a threshold artefact.

"Aim for 70, 80, 100 ng/mL." Above 50 ng/mL there is essentially no trial evidence of additional benefit, and for several outcomes the dose-response curve flattens or bends back down. The high targets came from observational data and from extrapolation, not from trials showing the high group does better than the medium group.

"D3 needs K2 or it'll calcify your arteries." A favourite of supplement marketing, especially at the price-doubled D3+K2 combination. The mechanistic story (a vitamin-K-dependent protein directs calcium to bone rather than vessels) is genuinely plausible. The human trial evidence that K2 changes anything when you take ordinary doses of D3 is essentially absent. Not clearly wrong, not clearly necessary. Plain D3 is fine.

"Sunscreen is making everyone deficient." In the lab, SPF 30 blocks 95% of UVB and stops the synthesis pathway cold. In real life, people who use sunscreen regularly don't have meaningfully lower vitamin D than people who don't. The reason is the obvious one: nobody applies sunscreen the way the lab tests do, and the incidental sun on your hands and face walking to lunch turns out to be plenty.

What to buy

D3 is one of the cheapest things in the supplement aisle. A year's supply of 1,000- or 2,000-IU softgels runs five to fifteen dollars from the bulk-supplement section of any pharmacy or online retailer. Liquid drops for children or anyone who hates pills cost a little more. Stick to plain D3 — combination products that bury an underdose alongside calcium, K2, magnesium, and a price markup are not the move; if you want those other things, buy them separately and at honest doses.

The 25(OH)D blood test runs $30–60 cash through direct-to-consumer labs in the US and is reimbursed by most insurance when ordered for documented risk factors. The LC-MS/MS method is the gold standard at low concentrations; standard immunoassay is usually fine. One test, once, to know where you stand on your usual dose — then stop thinking about it unless something changes (you move, you lose a lot of weight, you start a new medication that affects it).

Sunlight and food, for what they're worth

Vitamin D came from sunlight long before it came from softgels, and in the right conditions sunlight is still by far the most efficient delivery system. Ten to thirty minutes of midday summer sun on bare arms and face will produce several thousand IU of D3 in fair-skinned adults — vastly more than any reasonable supplement dose, and bundled with the unrelated mood and circadian benefits of bright light per se. The catch is that this works only when the UV index is high enough, which is roughly April through September above 35° latitude (most of the US north of Atlanta, all of the UK, most of continental Europe). October through March in those places, your skin makes essentially zero D3 no matter how clear the sky.

Food can carry meaningful amounts if you eat the right things deliberately. Wild salmon and other fatty fish run 600–1,000 IU per 100 g serving; canned mackerel and sardines, 200–500 IU; cod liver oil, around 1,000 IU per teaspoon; egg yolks about 40 IU each; UV-exposed mushrooms carry D2 (not D3). Fortified milk and orange juice add ~100 IU per cup. Reaching 1,000 IU/day from food alone is achievable but requires intent.

For most readers the honest answer is "all of the above": get sun when the season offers it, eat the fish, take the pill in winter, stop worrying about it.

What you actually get

The honest forecast depends mostly on where you started. Three rough cases.

If you started genuinely deficient (under 15 ng/mL): six to eight weeks in, the heavy-legs fatigue lifts. The bone ache, if you had it, eases. Through the next winter, the colds that used to flatten you are shorter and milder. Your blood test comes back somewhere readable. The change is felt — modest, real — because there was a deficit, and you closed it.

If you started mildly insufficient (15–25 ng/mL, the modal case for indoor adults at northern latitudes): nothing dramatic happens day to day. Your winter goes a little better — one fewer cough that turns into a chest thing, a flatter energy floor through February — but it is the kind of change you notice only if you compare to last year. Across decades, the actuarial weather bends in your direction: a small reduction in all-cause mortality, a small reduction in cancer mortality, a small reduction in fall risk when you hit your seventies Bjelakovic et al. 2014, Bischoff-Ferrari et al. 2009. Nobody can point at the single year you bought back; it shows up across the population, not on any one chart.

If you started already replete (above 30 ng/mL year-round, somehow): you will not feel anything change. The big trial in this population — VITAL — found basically nothing on cancer, heart disease, depression, or fractures Manson et al. 2019, LeBoff et al. 2022, Okereke et al. 2020. The pill costs you nothing to keep taking, but the payoff is essentially insurance against ever sliding into the deficient group, not a transformation.

The reason most adults should still take it is that the cost of being wrong about which group you are in is asymmetric. A daily pill the price of nothing, on the off chance you were the indoor winter person who would have spent the next decade at 18 ng/mL. The pill bought you out of that. Quietly. In the background. The way most useful health decisions do their work.

Adjacent topics worth knowing about, each their own entry: morning sunlight (the natural pathway plus its independent circadian and mood payoff), magnesium (a cofactor for the hydroxylation steps; severe magnesium deficiency can blunt the response to D3), calcium intake (the classical bone partner; dose carefully and prefer food over supplements), and the 25(OH)D blood test itself as a standalone screening question.

·
561